Clinical Trials Browser

Carcinoma, Renal Cell × cemiplimab × 30 days × Clear all

NCT06699602 2026-03-04

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT07223541 2026-03-02

LAG-BOOST

Phase 2 Recruiting

Carcinoma, Renal Cell

NCT07188896 2026-02-23

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Phase 2 Recruiting

Carcinoma, Renal Cell